Consun Pharmaceutical Group Ltd. Financial Overview
Consun Pharmaceutical Group Ltd.'s market cap is currently HK$12.22B. The company's EPS TTM is HK$0.6389670745999999; its P/E ratio is 11.42; and it has a dividend yield of 4.23%. Consun Pharmaceutical Group Ltd. is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
